BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21993862)

  • 1. Genes differentially expressed in the peripheral zone compared to the transitional zone of the normal human prostate and their potential regulation by ETS factors.
    Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Wernert N
    Mol Med Rep; 2012 Jan; 5(1):32-6. PubMed ID: 21993862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?
    Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Perner S; Wernert N
    Mol Med Rep; 2012 Feb; 5(2):313-6. PubMed ID: 22038307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate.
    Zhao FJ; Han BM; Yu SQ; Xia SJ
    Asian J Androl; 2009 Mar; 11(2):176-82. PubMed ID: 19122679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation.
    Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Wernert N
    Int J Mol Med; 2011 Nov; 28(5):799-807. PubMed ID: 21833467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade.
    Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
    Int J Mol Med; 2011 Jun; 27(6):811-9. PubMed ID: 21424114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.
    Berglund AE; Rounbehler RJ; Gerke T; Awasthi S; Cheng CH; Takhar M; Davicioni E; Alshalalfa M; Erho N; Klein EA; Freedland SJ; Ross AE; Schaeffer EM; Trock BJ; Den RB; Cleveland JL; Park JY; Dhillon J; Yamoah K
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):292-302. PubMed ID: 30367117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate.
    Carlsson J; Helenius G; Karlsson MG; Andrén O; Klinga-Levan K; Olsson B
    BMC Cancer; 2013 Jul; 13():362. PubMed ID: 23890084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.
    Camões MJ; Paulo P; Ribeiro FR; Barros-Silva JD; Almeida M; Costa VL; Cerveira N; Skotheim RI; Lothe RA; Henrique R; Jerónimo C; Teixeira MR
    PLoS One; 2012; 7(11):e49819. PubMed ID: 23185447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
    Zhao H; Ramos CF; Brooks JD; Peehl DM
    J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.
    Paulo P; Ribeiro FR; Santos J; Mesquita D; Almeida M; Barros-Silva JD; Itkonen H; Henrique R; Jerónimo C; Sveen A; Mills IG; Skotheim RI; Lothe RA; Teixeira MR
    Neoplasia; 2012 Jul; 14(7):600-11. PubMed ID: 22904677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of the human prostate zones.
    van der Heul-Nieuwenhuijsen L; Hendriksen PJ; van der Kwast TH; Jenster G
    BJU Int; 2006 Oct; 98(4):886-97. PubMed ID: 16978289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines.
    Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
    Int J Mol Med; 2011 Jul; 28(1):89-93. PubMed ID: 21491078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
    Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
    PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry.
    Gopalan A; Leversha MA; Dudas ME; Maschino AC; Chang J; Al-Ahmadie HA; Chen YB; Tickoo SK; Reuter VE; Fine SW
    Histopathology; 2013 Aug; 63(2):279-86. PubMed ID: 23701505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular disorders in transitional vs. peripheral zone prostate adenocarcinoma.
    Colombo P; Patriarca C; Alfano RM; Cassani B; Ceva Grimaldi G; Roncalli M; Bosari S; Coggi G; Campo B; Gould VE
    Int J Cancer; 2001 Nov; 94(3):383-9. PubMed ID: 11745418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
    Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
    Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
    Sakai I; Harada K; Hara I; Eto H; Miyake H
    BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do prostatic transition zone tumors have a distinct morphology?
    Garcia JJ; Al-Ahmadie HA; Gopalan A; Tickoo SK; Scardino PT; Reuter VE; Fine SW
    Am J Surg Pathol; 2008 Nov; 32(11):1709-14. PubMed ID: 18769336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS fusion genes in prostate cancer.
    Gasi Tandefelt D; Boormans J; Hermans K; Trapman J
    Endocr Relat Cancer; 2014 Jun; 21(3):R143-52. PubMed ID: 24659477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
    Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.